Impact of an Adherence Program on the Health and Outlook of HIV-Infected Patients Failing Antiretroviral Therapy

Abstract

Background: We prospectively studied the impact of an adherence counselor on the outcome of patients failing antiretroviral therapy because of nonadherence. Methods: Forty-six patients, identified as chronically nonadherent were enrolled. Individual attention was provided using the information, motivation and behavioral methodology. HIV RNA (viral load, in copies/mL), CD4 count (in cells/mm ³ ), and body weight before and after the adherence counselor were measured. Qualitative outcome and patient satisfaction were assessed by deidentified third-party interviews. Results: Over half completed at least 1 year; only 8 patients were lost to follow-up. Mean CD4 counts increased significantly ( P < .05) for completers at 6 and 12 months. Viral loads decreased between baseline and 6 months. Most clients reported subjective benefit from working with the adherence counselor. Conclusion: Although few clients showed complete virologic suppression, the value of an adherence counselor was validated. Longer term adherence programs should be evaluated.

Keywords

adherence failure of medical management compliance counseling HIV outcomes

References

AIDS Info . Antiretroviral treatment: guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. Available at: www.aidsinfo.nih.gov/guidelines. Accessed March 2003.

Chesney MA , Ickovics J , Hecht FM , Sikipa G , Rabkin J. Adherence: a necessity for successful HIV combination therapy. AIDS. 1999;13(suppl A):S271-S278.

Paterson DL , Swindells S , Mohr J , et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133:21-30.

Williams A , Friedland G. Adherence, compliance and HAART. AIDS Clin Care. 1997;9:51-54.

Wood E , Montaner JS , Yip B , et al. Adherence to antiretroviral therapy and CD4 T-cell count responses among HIV-infected injection drug users. Antiviral Ther. 2004;9:229-235.

Parienti JJ , Massari V , Descamps D , et al. Predictors of virologic failure and resistance in HIV-infected patients treated with nevirapine- or efavirenz-based antiretroviral therapy. Clin Infect Dis. 2004;38:1311-1316.

Wood E , Hogg RS , Yip B , Harrigan PR , O’Shaughnessy MV , Montaner JS . The impact of adherence on CD4 cell count responses among HIV-infected patients. J Acquir Immune Defic Syndr. 2004;35:261-268.

Wood E , Hogg RS , Yip B , Harrigan PR , O’Shaughnessy MV , Montaner JS . Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4+ cell count is 0.200 to 0.350 × 10(9) cells/L. Ann Intern Med. 2003;139:810-816.

Hippocrates, Decorum. circa 400 BC.

10.

Lucas GM , Chaisson RE , Moore RD . Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions. Ann Intern Med. 1999;131:81-87.

11.

Roberts KJ . Barriers to and facilitators of HIV-positive patients’ adherence to antiretroviral treatment regimens. AIDS Patient Care STDS. 2000;14:155-168.

12.

Reynolds NR , Testa MA , Marc LG , et al. Factors influencing medication adherence beliefs and self-efficacy in persons naive to antiretroviral therapy: a multicenter, cross-sectional study. AIDS Behav. 2004;8:141-150.

13.

Bontempi JM , Burleson L , Lopez MH . HIV medication adherence programs: the importance of social support. J Community Health Nurs. 2004;21:111-122.

14.

Weber R , Christen L , Christen S , et al. Effect of individual cognitive behaviour intervention on adherence to antiretroviral therapy: prospective randomized trial. Antivir Ther. 2004;9:85-95.

15.

Enriquez M , Gore PA Jr , O’Connor MC , McKinsey DS . Assessment of readiness for adherence by HIV-positive males who had previously failed treatment. J Assoc Nurses AIDS Care. 2004;15:42-49.

16.

Workman C. The process of supporting adherence. Focus. 1999;14: 1-4.

17.

Crisp BR , Williams M , Timpson S , Ross MW . Medication compliance and satisfaction with treatment for HIV disease in a sample of African-American crack cocaine smokers. AIDS Behav. 2004;8:199-206.

18.

Fisher JD , Fisher WA , Misovich SJ , Bryan AD . Information-motivation-behavioral skills model-based HIV risk behavior change intervention for inner-city high school youth. Health Psychol. 2002;21:177-186.

19.

Enriquez M , Lackey NR , O’Connor MC , McKinsey DS . Successful adherence after multiple HIV treatment failures. J Adv Nurs. 2004;45:438-446.

20.

Hill Z , Kendall C , Fernandez M. Patterns of adherence to antiretrovirals: why adherence has no simple measure. AIDS Patient Care STDS. 2003;17:519-525.

21.

Ickovics JR , Meisler AW . Adherence in AIDS clinical trials: a framework for clinical research and clinical care. J Clin Epidemiol. 1997;50:385-391.

22.

Chesney MA . Factors affecting adherence to antiretroviral therapy. Clin Infect Dis. 2000;30(suppl 2):S171-S176.

23.

Ammassari A , Murri R , Pezzotti P , et al. Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection. J Acquir Immune Def Syndr. 2002;28: 445-449.

24.

Ashman JJ , Conviser R , Pounds MB . Associations between HIV-positive individuals’ receipt of ancillary services and medical care receipt and retention. AIDS Care. 2002;14(suppl 1):S109-S118.

25.

Bangsberg DR , Hecht FM , Clague H. Provider assessment of adherence to HIV antiretroviral therapy. J Acquir Immune Defic Syndr. 2001;26:435-442.

26.

Simoni JM , Frick PA , Pantalone DW , Turner BJ . Antiretroviral adherence interventions: a review of current literature and ongoing studies. Top HIV Med. 2003;11:185-198.

27.

Ryan GW , Wagner GJ . Pill taking ‘routinization’: a critical factor to understanding episodic medication adherence. AIDS Care. 2003;15:795-806.

28.

Golin CE , Smith SR , Reif S. Adherence counseling practices of generalists and specialist physicians caring for people living with HIV/AIDS in North Carolina. J Gen Intern Med. 2004;19:16-27.